High levels of OPN expression in tissue and blood have been reported in patients with cancer [36, 37], infectious diseases such as HAD [38, 39], autoimmune disorders including multiple sclerosis and rheumatoid arthritis [40–42], obesity and diabetes [43, 44]. Here, SPP1 is linked to obesity due to melanocortin 4 receptor deficiency.